Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:09 pm Sale |
2022-12-31 | 13G | Allena Pharmaceuticals, Inc. ALNAQ |
Third Rock Ventures II L.P. | 0 0.000% |
-2,790,964 (Position Closed) |
Filing History |
| 2023-02-14 4:06 pm Sale |
2022-12-31 | 13G | Jounce Therapeutics, Inc. JNCE |
Third Rock Ventures II L.P. | 335,533 0.600% |
-3,794,934 (-91.88%) |
Filing History |
| 2022-02-14 4:52 pm Sale |
2021-12-31 | 13G | Jounce Therapeutics, Inc. JNCE |
Third Rock Ventures II L.P. | 4,130,467 8.100% |
-8,209,361 (-66.53%) |
Filing History |
| 2021-02-16 4:06 pm Sale |
2020-12-31 | 13G | Jounce Therapeutics, Inc. JNCE |
Third Rock Ventures II L.P. | 12,339,828 31.000% |
-939,292 (-7.07%) |
Filing History |